IMNM
Immunome (IMNM) Investor Questions
Review Immunome (IMNM) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Immunome
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 49
- Annual revenue
- $6.94M
- Annual net income
- $-212.39M
- Annual free cash flow
- $-206.85M
Immunome (IMNM) Investor Questions research
Immunome trades under the ticker IMNM. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review IMNM through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.